Roles of estrogen in the formation of intracranial aneurysms in ovariectomized female mice

Neurosurgery

Volumn 75, Issue 6, 2014, Pages 690-695

  Tada, Yoshiteru ^a   Makino, Hiroshi ^a   Furukawa, Hajime ^a   Shimada, Kenji ^a   Wada, Kosuke ^a   Liang, Elena I ^a   Murakami, Shoko ^a   Kudo, Mari ^a   Kung, David K ^b   Hasan, David M ^a   Kitazato, Keiko T ^c   Nagahiro, Shinji ^c   Lawton, Michael T ^a   Hashimoto, Tomoki ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Animal model; Estrogen; Inflammation; Intracranial aneurysm; Nitric oxide; Stroke

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; DIARYLPROPIONITRILE; ESTRADIOL; ESTROGEN; NITRIC OXIDE SYNTHASE INHIBITOR; 1,3,5-TRIS(4-HYDROXYPHENYL)-4-PROPYL-1H-PYRAZOLE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; NITRILE; PHENOL DERIVATIVE; PROPIONIC ACID DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; INCIDENCE; INTRACRANIAL ANEURYSM; KNOCKOUT MOUSE; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; PATHOPHYSIOLOGY; POSTMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; UPREGULATION; AGONISTS; ANIMAL; DISEASE MODEL; METABOLISM; SEXUAL DEVELOPMENT;

ANIMALS; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; INTRACRANIAL ANEURYSM; MALE; MICE; MICE, KNOCKOUT; NITRILES; OVARIECTOMY; PHENOLS; PROPIONATES; PYRAZOLES; SEX CHARACTERISTICS;

EID: 84925871499     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000528     Document Type: Article

References (33)

1. de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78(12):1365-1372.
2. Menghini VV, Brown RD Jr, Sicks JD, O'Fallon WM, Wiebers DO. Incidence and prevalence of intracranial aneurysms and hemorrhage in Olmsted County, Minnesota, 1965 to 1995. Neurology. 1998;51(2):405-411.
3. Stober T, Sen S, Anstatt T, Freier G, Schimrigk K. Direct evidence of hypertension and the possible role of post-menopause oestrogen deficiency in the pathogenesis of berry aneurysms. J Neurol. 1985;232(2):67-72.
4. Harrod CG, Batjer HH, Bendok BR. Deficiencies in estrogen-mediated regulation of cerebrovascular homeostasis may contribute to an increased risk of cerebral aneurysm pathogenesis and rupture in menopausal and postmenopausal women. Med Hypotheses. 2006;66(4):736-756.
5. Eden SV, Meurer WJ, Sanchez BN, et al. Gender and ethnic differences in subarachnoid hemorrhage. Neurology. 2008;71(10):731-735.
6. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science. 2005;308(5728):1583-1587.
7. Galea E, Santizo R, Feinstein DL, et al. Estrogen inhibits NF kappa B-dependent inflammation in brain endothelium without interfering with I kappa B degradation. Neuroreport. 2002;13(11):1469-1472.
8. Tada Y, Kanematsu Y, Kanematsu M, et al. A mouse model of intracranial aneurysm: technical considerations. Acta Neurochir Suppl. 2011;111:31-35.
9. Makino H, Tada Y, Wada K, et al. Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study. Stroke. 2012;43(9):2450-2456.
10. Kanematsu Y, Kanematsu M, Kurihara C, et al. Critical roles of macrophages in the formation of intracranial aneurysm. Stroke. 2011;42(1):173-178.
11. Nuki Y, Tsou TL, Kurihara C, Kanematsu M, Kanematsu Y, Hashimoto T. Elastase-induced intracranial aneurysms in hypertensive mice. Hypertension. 2009; 54(6):1337-1344.
12. Hess DT, Foster MW, Stamler JS. Assays for S-nitrosothiols and S-nitrosylated proteins and mechanistic insights into cardioprotection. Circulation. 2009;120(3): 190-193.
13. Nuedling S, Karas RH, Mendelsohn ME, et al. Activation of estrogen receptor beta is a prerequisite for estrogen-dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes. FEBS Lett. 2001;502(3):103-108.
14. Lin J, Steenbergen C, Murphy E, Sun J. Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection. Circulation. 2009;120 (3):245-254.
15. Leitman DC, Paruthiyil S, Vivar OI, et al. Regulation of specific target genes and biological responses by estrogen receptor subtype agonists. Curr Opin Pharmacol. 2010;10(6):629-636.
16. Tsutsumi S, Zhang X, Takata K, et al. Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2. J Endocrinol. 2008;199 (2):267-273.
17. HashimotoT,MengH, YoungWL. Intracranial aneurysms: links between inflammation, hemodynamics and vascular remodeling. Neurol Res. 2006;28(4):372-380.
18. Hasan DM, Mahaney KB, Brown RD Jr, et al. Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke. 2011;42(11):3156-3162.
19. Sun J, Picht E, Ginsburg KS, Bers DM, Steenbergen C, Murphy E. Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca21 channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ Res. 2006; 98(3):403-411.
20. Tymianski M. Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke. 2011;42(11):3003-3004.
21. Tamura T, Jamous MA, Kitazato KT, et al. Endothelial damage due to impaired nitric oxide bioavailability triggers cerebral aneurysm formation in female rats. J Hypertens. 2009;27(6):1284-1292.
22. Jamous MA, Nagahiro S, Kitazato KT, Tamura T, Kuwayama K, Satoh K. Role of estrogen deficiency in the formation and progression of cerebral aneurysms, part II: experimental study of the effects of hormone replacement therapy in rats. J Neurosurg. 2005;103(6):1052-1057.
23. Jamous MA, Nagahiro S, Kitazato KT, Satomi J, Satoh K. Role of estrogen deficiency in the formation and progression of cerebral aneurysms, part I: experimental study of the effect of oophorectomy in rats. J Neurosurg. 2005;103 (6):1046-1051.
24. Suzuki S, Brown CM, Dela Cruz CD, Yang E, Bridwell DA, Wise PM. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc Natl Acad Sci U S A. 2007;104 (14):6013-6018.
25. Toutain CE, Filipe C, Billon A, et al. Estrogen receptor alpha expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization. Arterioscler Thromb Vasc Biol. 2009;29(10):1543-1550.
26. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA. Estrogen receptor-beta potency-selective ligands: structure- activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem. 2001;44(24):4230-4251.
27. Cheng J, Hurn PD. Sex shapes experimental ischemic brain injury. Steroids. 2009; 75(11):754-759.
28. Krause DN, Duckles SP, Pelligrino DA. Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol. 2006;101(4):1252-1261.
29. Liu J, Divoux A, Sun J, et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med. 2009;15 (8):940-945.
30. Tiwari-Woodruff S, Morales LB, Lee R, Voskuhl RR. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc Natl Acad Sci U S A. 2007;104(37):14813-14818.
31. Frasor J, Barnett DH, Danes JM, Hess R, Parlow AF, Katzenellenbogen BS. Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus. Endocrinology. 2003;144(7):3159-3166.
32. Hendrix SL, Wassertheil-Smoller S, Johnson KC, et al. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation. 2006;113 (20):2425-2434.
33. Becker C. Another selective estrogen-receptor modulator for osteoporosis. N Engl J Med. 2010;362(8):752-754.